09 Sep 2021 Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases Member news
09 Sep 2021 ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs Member news
09 Sep 2021 Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology Member news
17 Aug 2021 Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science Member news
20 May 2021 reMYND announces Clinical Advisory Board to support development of Alzheimer’s programme Member news
20 May 2021 Eurofins Genomics meets global demand for SARS-CoV-2 full genome sequencing, with over 100,000 sequenced samples in less than 8 weeks Member news
11 May 2021 Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance Member news
07 May 2021 CD3 and VIB enter into an exclusive license and research collaboration with SpringWorks Therapeutics to develop TEAD inhibitors for addressing biomarker-defined cancers Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
